A transposon and transposase system for human application.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Perry B HackettL J N Cooper

Abstract

The stable introduction of therapeutic transgenes into human cells can be accomplished using viral and nonviral approaches. Transduction with clinical-grade recombinant viruses offers the potential of efficient gene transfer into primary cells and has a record of therapeutic successes. However, widespread application for gene therapy using viruses can be limited by their initially high cost of manufacture at a limited number of production facilities as well as a propensity for nonrandom patterns of integration. The ex vivo application of transposon-mediated gene transfer now offers an alternative to the use of viral vectors. Clinical-grade DNA plasmids can be prepared at much reduced cost and with lower immunogenicity, and the integration efficiency can be improved by the transient coexpression of a hyperactive transposase. This has facilitated the design of human trials using the Sleeping Beauty (SB) transposon system to introduce a chimeric antigen receptor (CAR) to redirect the specificity of human T cells. This review examines the rationale and safety implications of application of the SB system to genetically modify T cells to be manufactured in compliance with current good manufacturing practice (cGMP) for phase I/II trials.

References

May 10, 1995·Molecular & General Genetics : MGG·Z IzsvákP B Hackett
Sep 15, 1994·Nature·B CharlesworthW Stephan
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·Z IvicsP B Hackett
Sep 2, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S Henikoff
Apr 29, 1999·Cell·E U Selker
Feb 23, 2000·The Journal of Clinical Investigation·T H Bestor
May 10, 2000·Proceedings of the National Academy of Sciences of the United States of America·A C GrothM P Calos
Sep 26, 2000·Molecular and Cellular Biology·S R CherryR Jaenisch
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
May 22, 2001·Molecular and Cellular Biology·B ThyagarajanM P Calos
Jan 10, 2002·Human Gene Therapy·Jay N LozierRichard A Morgan
Jun 27, 2002·Journal of Molecular Biology·Zongbin CuiPerry B Hackett
Oct 16, 2002·Nature Biotechnology·Eric C OlivaresMichele P Calos
Dec 6, 2002·Nature·UNKNOWN Mouse Genome Sequencing ConsortiumEric S Lander
Dec 25, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Eugenio MontiniMarkus Grompe
Apr 2, 2003·Nature Medicine·C BoniniC Bordignon
Jun 5, 2003·Nature Genetics·Hiroyuki NakaiMark A Kay
Jul 5, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aron M GeurtsPerry B Hackett
Aug 9, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Donald B KohnUNKNOWN American Society of Gene Therapy (ASGT)
Nov 26, 2003·Current Opinion in Genetics & Development·Prescott L DeiningerHaig H Kazazian
Jan 13, 2004·The Journal of Gene Medicine·UNKNOWN Gene Therapy Expert Group of the Committee for Proprietary Medical Products (CPMP), UNKNOWN European Agency for the Evaluation of Medical Products
Jan 27, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher BaumDavid A Williams
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zsuzsanna Izsvák, Zoltán Ivics
Feb 18, 2004·World Journal of Gastroenterology : WJG·Chen-Xia HeJing-Lun Xue
Mar 10, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hans-Peter KiemCynthia E Dunbar
Mar 16, 2004·Science·Haig H Kazazian
Aug 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·John R OhlfestDavid A Largaespada
Feb 1, 2005·Trends in Genetics : TIG·Zoltán Ivics, Zsuzsanna Izsvák
Mar 2, 2005·Biochemical and Biophysical Research Communications·Zongyu J ChenClifford J Steer
Mar 4, 2005·Molecular and Cellular Biology·Stephen R YantMark A Kay
Jun 1, 2005·Biological Reviews of the Cambridge Philosophical Society·James A Shapiro, Richard von Sternberg
Jul 5, 2005·Trends in Biotechnology·Craig J CoatesAndreas F Kolb
Jul 5, 2005·Nature Reviews. Genetics·Corey M Carlson, David A Largaespada

❮ Previous
Next ❯

Citations

Dec 2, 2011·Cancer Immunology, Immunotherapy : CII·Michael Kalos
Dec 12, 2012·Current Hematologic Malignancy Reports·Chitra HosingElizabeth Shpall
Aug 13, 2013·Differentiation; Research in Biological Diversity·Richard P DavisChristine L Mummery
Jul 16, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jason B BellPerry B Hackett
Mar 2, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Donald B KohnHelen E Heslop
Jul 11, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katrin VoigtZoltán Ivics
Jan 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kosuke YusaNancy L Craig
Oct 3, 2012·Proceedings of the National Academy of Sciences of the United States of America·Daniel F CarlsonScott C Fahrenkrug
Jan 26, 2011·Human Gene Therapy·Cecilia N Barese, Cynthia E Dunbar
Oct 14, 2011·Human Gene Therapy·Joseph E DohertyMatthew H Wilson
Aug 27, 2011·Human Gene Therapy·Zoltán Ivics, Zsuzsanna Izsvák
Apr 5, 2011·Human Molecular Genetics·Elena L AronovichPerry B Hackett
Apr 21, 2011·Human Molecular Genetics·Lisa J Scherer, John J Rossi
May 26, 2011·Nucleic Acids Research·Melanie GallaChristopher Baum
Dec 6, 2012·Journal of Immunotherapy·Yozo NakazawaMatthew H Wilson
Dec 6, 2012·Journal of Immunotherapy·Richard A Morgan
Jul 19, 2011·Genome Research·John F ThompsonPatrice M Milos
Feb 3, 2012·Molekuliarnaia biologiia·E S KniazhanskaiaM B Gottikh
Dec 9, 2010·Mobile DNA·Zoltán Ivics, Zsuzsanna Izsvák
Apr 3, 2012·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yuriko Higuchi
Apr 5, 2013·PloS One·Leonardo ChicaybamMartin Hernan Bonamino
May 19, 2011·Yi chuan = Hereditas·Lin LiuYue Huang
Nov 15, 2012·Journal of Visualized Experiments : JoVE·Sunandan SahaMatthew H Wilson
Dec 18, 2013·International Journal of Hematology·Cameron J Turtle
Feb 4, 2014·Current Hematologic Malignancy Reports·Bipulendu JenaLaurence J N Cooper
Dec 7, 2013·International Journal of Hematology·Marco L DavilaRenier Brentjens
Apr 23, 2014·Journal of Bioscience and Bioengineering·Chunxiao Wu, Shu Wang
Dec 21, 2013·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Arthur A HurwitzZiqiang Zhu
Aug 2, 2011·Annual Review of Genomics and Human Genetics·Christine R BeckJohn V Moran
Jul 30, 2015·International Journal of Cancer. Journal International Du Cancer·Hye-Lim JuSimon Weonsang Ro
Dec 20, 2011·Expert Opinion on Biological Therapy·Marta SwierczekZoltán Ivics
Jan 14, 2016·Expert Opinion on Biological Therapy·Jessica Pahle, Wolfgang Walther
Dec 17, 2014·Expert Opinion on Drug Delivery·Daniel A WolfWalter C Low
Jun 12, 2012·Expert Opinion on Biological Therapy·Mario Di MatteoThierry Vandendriessche
Jan 26, 2016·ACS Biomaterials Science & Engineering·Zachary P TolstykaTheresa M Reineke
Jan 23, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Alisa DongLaura Breda
Dec 19, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Saar Gill, Michael Kalos
Jan 15, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Perry B HackettLaurence J N Cooper
Jul 18, 2012·Cytotherapy·David L Digiusto, Hans-Peter Kiem
Dec 20, 2011·Advanced Drug Delivery Reviews·Ling Zhang, Richard A Morgan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.